| RS397507508 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS397507509 |
PTPN11
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome 1 |
| RS397507510 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 3, Cardiovascular phenotype |
| RS397507511 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome |
| RS397507512 |
PTPN11
|
Health Risk |
Pathogenic |
Noonan syndrome, RASopathy |
| RS397507513 |
PTPN11
|
Health Risk |
Likely pathogenic |
Noonan syndrome 1, RASopathy |
| RS397507514 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, Noonan syndrome |
| RS397507517 |
PTPN11
|
Health Risk |
Likely pathogenic |
RASopathy, Noonan syndrome |
| RS397507518 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, Noonan syndrome 3 |
| RS397507519 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 1 |
| RS397507520 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, Juvenile myelomonocytic leukemia |
| RS397507523 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, Noonan syndrome 1 |
| RS397507524 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 1 |
| RS397507525 |
PTPN11
|
Health Risk |
Pathogenic |
Noonan syndrome, RASopathy |
| RS397507526 |
PTPN11
|
Health Risk |
Pathogenic |
Noonan syndrome 1, RASopathy |
| RS397507527 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, RASopathy |
| RS397507528 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 1, Metachondromatosis |
| RS397507529 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, Noonan syndrome with multiple lentigines |
| RS397507530 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, Noonan syndrome 1 |
| RS397507531 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
LEOPARD syndrome 1, Noonan syndrome 1 |
| RS397507536 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 1, RASopathy |
| RS397507537 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome with multiple lentigines |
| RS397507539 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, Noonan syndrome 1 |
| RS397507540 |
PTPN11
|
Health Risk |
Pathogenic |
Noonan syndrome, RASopathy |
| RS397507541 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, LEOPARD syndrome 1 |
| RS397507542 |
PTPN11
|
Health Risk |
Likely pathogenic |
RASopathy, LEOPARD syndrome 1 |
| RS397507543 |
PTPN11
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome, RASopathy |
| RS397507544 |
PTPN11
|
Health Risk |
Pathogenic |
Noonan syndrome, RASopathy |
| RS397507545 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, Noonan syndrome 1 |
| RS397507546 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, LEOPARD syndrome 1 |
| RS397507547 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, Noonan syndrome |
| RS397507548 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, LEOPARD syndrome 1 |
| RS397507549 |
PTPN11
|
Health Risk |
Pathogenic |
Embryonal rhabdomyosarcoma, RASopathy |
| RS397507550 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, Cardiovascular phenotype |
| RS397507552 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS397507553 |
FANCA;ZNF276
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS397507554 |
RPS7
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 8, Diamond-Blackfan anemia 8 |
| RS397507555 |
CASQ2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS397507556 |
CASQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 2, Long QT syndrome |
| RS397507559 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS397507560 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS397507561 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS397507562 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis type II, Mucolipidosis |
| RS397507563 |
FLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Ichthyosis vulgaris, Incidental Discovery |
| RS397507568 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397507569 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507570 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507571 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507572 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507573 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397507574 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507575 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507576 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507577 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507578 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507579 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507580 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507581 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507583 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507584 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507586 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507587 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507588 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507589 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507591 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507592 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507593 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507594 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507597 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507598 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507599 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507600 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507601 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507602 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397507603 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507604 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS397507605 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507606 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507607 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397507608 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507610 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507611 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507612 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507613 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507614 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507615 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS397507616 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507617 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507618 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507619 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507620 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS397507621 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507623 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397507624 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507625 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507627 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS397507628 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS397507629 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS397507630 |
BRCA2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS397507631 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |